Oak Brook OCD & Complex Anxiety Program for Children

CHICAGO, May 2, 2023 (Newswire.com) - According to recent data collected by the Centers for Disease Control (CDC) between 2016-2019, more than 5.8 million children between the ages of 3-17 in the United States had been diagnosed with an anxiety disorder. These numbers have only increased since the start of the pandemic. In response to this need, Compass Health Center's Oak Brook location has opened its new Obsessive Compulsive Disorder (OCD) & Complex Anxiety Program for children ages 8-13.

This new program complements Compass's Adolescent program for ages 13-18 and supports children whose OCD and other more complex anxiety symptoms persistently interfere with daily functioning. In children, these diagnoses often present as refusal to leave home or attend school, refusal to participate in the classroom, excessive worry, sleep disturbances, and physical health concerns like chronic headaches and stomachaches.

"Since opening our doors to the child population in the West suburbs, we have seen the continued need for more specialized treatment when it comes to OCD and other anxiety disorders. We are excited to offer a more tailored approach to treating OCD and Anxiety with Exposure and Response Prevention (ERP). Having recently launched this specialty in our Adolescent Program, we have seen improved outcomes with these patients and their families and look forward to offering this to our child patients and families as well," said Katrina Shannon, LMFT, Director of Child and Adolescent Programs, Compass Health Center - Oak Brook. 

Compass's evidence-based OCD and Complex Anxiety Partial Hospitalization (PHP) and Intensive Outpatient (IOP) programming introduces children to exposure therapy, one of the most effective treatments for OCD and other anxiety disorders, such as Separation Anxiety Disorder, Social Anxiety Disorder, and Panic Disorder. In addition to attending group and family therapy sessions, children in the program meet with dedicated exposure therapists to address their fears and the avoidance strategies the patients have adopted to manage their fears.  

Children are taught to recognize the negative impact these avoidance strategies are having on their lives and are supported in gradually decreasing their avoidance behaviors. As the child slowly comes into contact with their fears, they learn to function in the presence of their fears and eventually to think about their fears differently. As part of Compass's individualized care model, children participate in family therapy with one or more of their family members, allowing for the family to learn how best to support their anxious child and how not to support their avoidance strategies. 

Ninety percent of Compass's child program participants successfully complete the program and experience a significant reduction in anxiety symptoms. In addition, 95 percent of children in Compass programming avoid hospitalization due to mental health symptoms.  

"We successfully treat these symptoms and diagnoses in our specialty programs for adolescents and adults in Oak Brook and for all ages at our other locations. We are excited to expand these services in a specialized way to children as young as 8 years old and their families in the communities served by our Oak Brook location," said Kerry Lusignan, LCSW, Chief Clinical Officer, Compass Health Center - Oak Brook. 

Compass's expert clinical team of masters-level clinicians understands and focuses on the individualized approach to treatment, which helps children in moving towards achieving a meaningful and functional life. Learn more: https://compasshealthcenter.net/  

Polar Seal Training Academy

SURREY, U.K., May 2, 2023 (Newswire.com) - According to a survey conducted by YouGov in July 2022, 50% of British workers reported feeling stressed at work. Another article by Investors In People mentioned companies that invested in employee well-being may reduce turnover and its associated costs. 

Recognising the rapid pace of technological advancements and changes in the medical industry, PolarSeal has taken a proactive approach by investing in the professional development of its employees. The Training Academy is a testament to PolarSeal's dedication to employee development and growth.

The Training Academy will offer a variety of training programs and courses, ranging from leadership, quality, H&S, Lean/SixSigma, 5 Why Problem Solving Techniques, Total Productive Maintenance and machine setup. The courses will be designed and delivered by industry experts and tailored to the specific needs of PolarSeal's employees to shape a set of behavioural routines that characterise the way tasks are completed.

"We are thrilled to launch our new Training Academy and provide our employees with the tools and resources they need to succeed in their roles and advance their careers," said Giles O'Sullivan-Wade, Continuous Improvement Manager of PolarSeal. 

"Uplifting and investing in our employees' professional development is a key priority for us, and we believe it will ultimately benefit our customers and our business as a whole. The training academy also helps underpin one of PolarSeal's strengths: that it brings together people from all walks of life and every corner of the globe, uniting many who would not normally work alongside each other. PolarSeal offers opportunity, structure and example that creates bonds of trust and understanding."

PolarSeal's Operational Excellence philosophy emphasises the importance of continuous improvement to optimise the performance of its people and its equipment. By investing in its workforce, PolarSeal ensures that its employees have the necessary skills and knowledge to perform manufacturing tasks efficiently and effectively. This not only improves safe and efficient ways of working but reduces downtime and costs associated with equipment failure, helping to improve the overall quality and consistency of the service that PolarSeal delivers to its customers. 

PolarSeal's new Training Academy is part of the company's ongoing efforts to prioritise employee development and well-being. The company offers a range of benefits and initiatives to support its employees, including flexible work arrangements, wellness programs, and career development opportunities.

About PolarSeal

PolarSeal is a leading medical device contract manufacturer and flexible material converter. With a commitment to innovation, quality, and global well-being, PolarSeal has become a leading solution provider in the medical industry. 

For more information about PolarSeal and its Training Academy, visit the company's website at https://www.polarseal.net/ 

Best Practices Award - Imagene
Imagene won the 2023 Technology Innovation Leadership Award in AI-based molecular testing for cancer diagnosis.

TEL AVIV, Israel, May 2, 2023 (Newswire.com) - Imagene, an emerging leader in the field of AI-based precision oncology, is proud to announce its win of the Frost & Sullivan 2023 Europe Technology Innovation Leadership Award in AI-based molecular testing for cancer diagnosis.

Frost & Sullivan Best Practices awards recognize companies for demonstrating outstanding achievement and superior performance in leadership and technological innovation. Imagene AI has been acknowledged for its groundbreaking technology and commitment to innovation and creativity in supporting physicians and patients.

Ashish Kaul, industry analyst at Frost & Sullivan, said, "Imagene's AI-based molecular testing technology scales to streamline cancer care processes and needs. It accelerates cancer diagnosis via accurate, image-based, immediate biomarker profiling, overcoming existing barriers and revolutionizing the market. Frost & Sullivan anticipates rapid, widespread technology adoption."

Imagene AI's technology can detect a wide range of cancer biomarkers in real-time, generating immediate genomic insights from digitized biopsy images alone. By reducing the time-to-results of molecular testing from several weeks to minutes, Imagene's AI-based solution transforms cancer diagnosis and advances precision medicine.

"We are honored to receive this prestigious award from Frost & Sullivan, which validates our dedication to delivering world-class AI-based molecular testing solutions for cancer diagnosis," said Dean Bitan, Co-founder and CEO of Imagene. "Our mission is to provide healthcare professionals with immediate and accurate biomarker profiling, empowering them with crucial information that enables optimal navigation in the complex cancer diagnosis process. This recognition affirms our commitment to innovation and to helping cancer patients in getting the most optimal treatment medicine can offer."

Frost & Sullivan recognizes the high value and accuracy levels of Imagene's AI-based molecular diagnosis solution and its strategic partnerships with leading medical centers and pharmaceutical companies worldwide. Imagene's technology also supports pharmaceutical companies' drug research and development activities, enabling optimal patient stratification for clinical trial optimization.

With its strong overall performance and dedication for bringing value to physicians and patients, Imagene AI is poised to set new market trends and address unmet needs in cancer care. The Frost & Sullivan 2023 Europe Technology Innovation Leadership Award recognizes Imagene's ongoing excellence and pioneering leadership role in the AI-based molecular testing for cancer diagnosis market.

About Imagene

Imagene is an emerging leader in the field of AI-based precision oncology, leveraging AI to profile, in real-time, a broad range of cancer biomarkers from a digitized biopsy image alone. Imagene's AI-based molecular diagnostic solutions streamline cancer care processes and accelerate cancer diagnosis through precise, image-based, immediate biomarkers profiling. 

Imagene is an award-winning diverse BioMed startup with an experienced, passionate and bright team. Our success derives from our cutting-edge technology and multidisciplinary team of data scientists, biologists, software engineers, and medical experts. The company collaborates with top-tier medical centers and pharmaceutical companies worldwide. 

For more information, visit www.imagene.ai.

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Starrag's Bumotec 191neo
Bone plate manufacturing on the Bumotec 191neo

HEBRON, Ky., May 2, 2023 (Newswire.com) - With 12 different variants built upon a single platform, the new Starrag Bumotec 191^neo is a multi-axis mill/turn center that introduces a world of flexible and highly productive machining solutions. At the OMTEC exhibition, the Starrag Bumotec 191^neo will be demonstrating just how flexible, productive and capable a machine it is with the one-hit production of a bone plate. Manufactured in volume throughout the medical industry, bone plates are particularly challenging to machine - but not for the Starrag Bumotec 191^neo.

For manufacturers in the medical profession, the difficulty when producing bone plates is the ability to machine and subsequently finish the plates on all six sides in a single operation whilst striving for optimized cycle times and lights-out 24/7 production. On the booth at OMTEC, the machine will feed a 1.2-inch (30 mm) diameter titanium bar into the work envelope and deploy 20 different cutting tools to 26 operations to finish machine the bone plate in under 20 minutes. The challenge, as a medical device manufacturer would appreciate, is the complex machining of a long part between two stations whilst retaining perfect synchronization. Not only does the new Starrag Bumotec 191^neo productively achieve this by machining the bone plates from bar stock in its robust work envelope, but it eradicates any requirement for secondary operations. 

The epitome of high-end machining, the Starrag Bumotec 191^neo will machine the bone plate at OMTEC in a single operation with impeccable surface finishes, leaving a part that is burr-free and free of tabs - and then delicately placing the parts into a collection receptacle for complete unmanned production. With such stringent regulations in the medical industry, machining bone plates with absolute confidence and quality conformity whilst delivering a completely automated production cell is exactly why manufacturers need to see the Starrag Bumotec 191^neo at OMTEC. 

The impressive new Starrag Bumotec 191^neo is available in four versions, the 'P' with vice, 'PRM' with a multi-purpose pickup vice, the 'R' with a back-working spindle and the 'RP' with a combined vice and back-working spindle. Providing a choice of bar capacities of 1.7, 2, 2.6 inch (42, 50 or 65 mm), manufacturers can choose one of 12 machine configurations that are all based upon the same rigid and extremely robust. 

Maintaining unparalleled thermal and performance stability during production, the Starrag Bumotec 191^neo offers a formidable level of productivity. Compared to previous models, the new machine has a new tool change system that reduces changeovers by more than 15%. The machine also has a new milling spindle with increased torque and a back-working movement that is controlled by an electric motor. This combination provides the perfect blend of high-speed cutting with the power and rigidity for increased material removal rates whilst enhancing positional control.

The high-performance Starrag spindle is fed cutting tools from its 90-position tool magazine that now has an integrated tool breakage probe to support lights-out production runs. Further advancing the automation credentials of the new machine is the option of a traditional Bumotec palletizer or a robotic, modular or custom-made automated cell that delivers true '24/7' production, which is only interrupted by preventive maintenance when required. If you want to optimize your productivity with a completely flexible solution that can undertake the machining of a diverse range of component types, please come and visit Booth 447 at the OMTEC show in June.